Gut brain axis: Difference between revisions
No edit summary |
|||
Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{gut brain axis}} | {{gut brain axis}} | ||
{{CMG}} {{AE}} {{S.G.}} | {{CMG}} {{AE}} {{S.G.}} | ||
Line 5: | Line 6: | ||
==Historical Perspective== | ==Historical Perspective== | ||
* | |||
* | |||
*The '''gut–brain axis''' is the biochemical signaling between the central nervous system (CNS) and the gastrointestinal tract (GI tract). | |||
*Gut brian axis was first discovered by [scientist name], a [nationality + occupation], in [year] during/following [event]. | |||
*In [year], [gene] mutations were first identified in the pathogenesis of [disease name]. | *In [year], [gene] mutations were first identified in the pathogenesis of [disease name]. | ||
*In [year], the first [discovery] was developed by [scientist] to treat/diagnose [disease name]. | *In [year], the first [discovery] was developed by [scientist] to treat/diagnose [disease name]. | ||
==Classification== | ==Classification== | ||
*[Disease name] may be classified according to [classification method] into [number] subtypes/groups: | *[Disease name] may be classified according to [classification method] into [number] subtypes/groups: | ||
:*[group1] | :*[group1] | ||
:*[group2] | :*[group2] | ||
:*[group3] | :*[group3] | ||
*Other variants of [disease name] include [disease subtype 1], [disease subtype 2], and [disease subtype 3]. | *Other variants of [disease name] include [disease subtype 1], [disease subtype 2], and [disease subtype 3]. | ||
==Pathophysiology== | ==Pathophysiology== | ||
*The pathogenesis of [disease name] is characterized by [feature1], [feature2], and [feature3]. | *The pathogenesis of [disease name] is characterized by [feature1], [feature2], and [feature3]. | ||
*The [gene name] gene/Mutation in [gene name] has been associated with the development of [disease name], involving the [molecular pathway] pathway. | *The [gene name] gene/Mutation in [gene name] has been associated with the development of [disease name], involving the [molecular pathway] pathway. | ||
*On gross pathology, [feature1], [feature2], and [feature3] are characteristic findings of [disease name]. | *On gross pathology, [feature1], [feature2], and [feature3] are characteristic findings of [disease name]. | ||
*On microscopic histopathological analysis, [feature1], [feature2], and [feature3] are characteristic findings of [disease name]. | *On microscopic histopathological analysis, [feature1], [feature2], and [feature3] are characteristic findings of [disease name]. | ||
==Causes== | ==Causes== | ||
Disease name] may be caused by [cause1], [cause2], or [cause3]. | Disease name] may be caused by [cause1], [cause2], or [cause3]. | ||
Line 36: | Line 45: | ||
The cause of [disease name] has not been identified. To review risk factors for the development of [disease name], click [[Pericarditis causes#Overview|here]]. | The cause of [disease name] has not been identified. To review risk factors for the development of [disease name], click [[Pericarditis causes#Overview|here]]. | ||
==Differentiating [disease name] from other Diseases== | ==Differentiating [disease name] from other Diseases== | ||
*[Disease name] must be differentiated from other diseases that cause [clinical feature 1], [clinical feature 2], and [clinical feature 3], such as: | *[Disease name] must be differentiated from other diseases that cause [clinical feature 1], [clinical feature 2], and [clinical feature 3], such as: | ||
:*[Differential dx1] | :*[Differential dx1] | ||
:*[Differential dx2] | :*[Differential dx2] | ||
Line 42: | Line 53: | ||
==Epidemiology and Demographics== | ==Epidemiology and Demographics== | ||
* The prevalence of [disease name] is approximately [number or range] per 100,000 individuals worldwide. | |||
* In [year], the incidence of [disease name] was estimated to be [number or range] cases per 100,000 individuals in [location]. | *The prevalence of [disease name] is approximately [number or range] per 100,000 individuals worldwide. | ||
*In [year], the incidence of [disease name] was estimated to be [number or range] cases per 100,000 individuals in [location]. | |||
===Age=== | ===Age=== | ||
*Patients of all age groups may develop [disease name]. | *Patients of all age groups may develop [disease name]. | ||
Line 52: | Line 65: | ||
===Gender=== | ===Gender=== | ||
*[Disease name] affects men and women equally. | *[Disease name] affects men and women equally. | ||
*[Gender 1] are more commonly affected with [disease name] than [gender 2]. | *[Gender 1] are more commonly affected with [disease name] than [gender 2]. | ||
* The [gender 1] to [Gender 2] ratio is approximately [number > 1] to 1. | *The [gender 1] to [Gender 2] ratio is approximately [number > 1] to 1. | ||
===Race=== | ===Race=== | ||
*There is no racial predilection for [disease name]. | *There is no racial predilection for [disease name]. | ||
Line 64: | Line 79: | ||
==Risk Factors== | ==Risk Factors== | ||
*Common risk factors in the development of [disease name] are [risk factor 1], [risk factor 2], [risk factor 3], and [risk factor 4]. | *Common risk factors in the development of [disease name] are [risk factor 1], [risk factor 2], [risk factor 3], and [risk factor 4]. | ||
== Natural History, Complications and Prognosis== | ==Natural History, Complications and Prognosis== | ||
*The majority of patients with [disease name] remain asymptomatic for [duration/years]. | |||
*The majority of patients with [disease name] remain asymptomatic for [duration/years]. | |||
*Early clinical features include [manifestation 1], [manifestation 2], and [manifestation 3]. | *Early clinical features include [manifestation 1], [manifestation 2], and [manifestation 3]. | ||
*If left untreated, [#%] of patients with [disease name] may progress to develop [manifestation 1], [manifestation 2], and [manifestation 3]. | *If left untreated, [#%] of patients with [disease name] may progress to develop [manifestation 1], [manifestation 2], and [manifestation 3]. | ||
Line 73: | Line 90: | ||
*Prognosis is generally [excellent/good/poor], and the [1/5/10year mortality/survival rate] of patients with [disease name] is approximately [#%]. | *Prognosis is generally [excellent/good/poor], and the [1/5/10year mortality/survival rate] of patients with [disease name] is approximately [#%]. | ||
== Diagnosis == | ==Diagnosis== | ||
===Diagnostic Criteria=== | ===Diagnostic Criteria=== | ||
*The diagnosis of [disease name] is made when at least [number] of the following [number] diagnostic criteria are met: | *The diagnosis of [disease name] is made when at least [number] of the following [number] diagnostic criteria are met: | ||
:*[criterion 1] | :*[criterion 1] | ||
:*[criterion 2] | :*[criterion 2] | ||
Line 81: | Line 100: | ||
:*[criterion 4] | :*[criterion 4] | ||
=== History and Symptoms === | ===History and Symptoms=== | ||
*[Disease name] is usually asymptomatic. | *[Disease name] is usually asymptomatic. | ||
*Symptoms of [disease name] may include the following: | *Symptoms of [disease name] may include the following: | ||
:*[symptom 1] | :*[symptom 1] | ||
:*[symptom 2] | :*[symptom 2] | ||
Line 91: | Line 112: | ||
:*[symptom 6] | :*[symptom 6] | ||
=== Physical Examination === | ===Physical Examination=== | ||
*Patients with [disease name] usually appear [general appearance]. | *Patients with [disease name] usually appear [general appearance]. | ||
*Physical examination may be remarkable for: | *Physical examination may be remarkable for: | ||
:*[finding 1] | :*[finding 1] | ||
:*[finding 2] | :*[finding 2] | ||
Line 101: | Line 124: | ||
:*[finding 6] | :*[finding 6] | ||
=== Laboratory Findings === | ===Laboratory Findings=== | ||
*There are no specific laboratory findings associated with [disease name]. | *There are no specific laboratory findings associated with [disease name]. | ||
Line 107: | Line 131: | ||
*An [elevated/reduced] concentration of [serum/blood/urinary/CSF/other] [lab test] is diagnostic of [disease name]. | *An [elevated/reduced] concentration of [serum/blood/urinary/CSF/other] [lab test] is diagnostic of [disease name]. | ||
*Other laboratory findings consistent with the diagnosis of [disease name] include [abnormal test 1], [abnormal test 2], and [abnormal test 3]. | *Other laboratory findings consistent with the diagnosis of [disease name] include [abnormal test 1], [abnormal test 2], and [abnormal test 3]. | ||
===Electrocardiogram=== | ===Electrocardiogram=== | ||
There are no ECG findings associated with [disease name]. | There are no ECG findings associated with [disease name]. | ||
Line 176: | Line 201: | ||
Other diagnostic studies for [disease name] include [diagnostic study 1], which demonstrates [finding 1], [finding 2], and [finding 3], and [diagnostic study 2], which demonstrates [finding 1], [finding 2], and [finding 3]. | Other diagnostic studies for [disease name] include [diagnostic study 1], which demonstrates [finding 1], [finding 2], and [finding 3], and [diagnostic study 2], which demonstrates [finding 1], [finding 2], and [finding 3]. | ||
== Treatment == | ==Treatment== | ||
=== Medical Therapy === | ===Medical Therapy=== | ||
*There is no treatment for [disease name]; the mainstay of therapy is supportive care. | *There is no treatment for [disease name]; the mainstay of therapy is supportive care. | ||
Line 184: | Line 210: | ||
*Response to [medical therapy 1] can be monitored with [test/physical finding/imaging] every [frequency/duration]. | *Response to [medical therapy 1] can be monitored with [test/physical finding/imaging] every [frequency/duration]. | ||
=== Surgery === | ===Surgery=== | ||
*Surgery is the mainstay of therapy for [disease name]. | *Surgery is the mainstay of therapy for [disease name]. | ||
*[Surgical procedure] in conjunction with [chemotherapy/radiation] is the most common approach to the treatment of [disease name]. | *[Surgical procedure] in conjunction with [chemotherapy/radiation] is the most common approach to the treatment of [disease name]. | ||
*[Surgical procedure] can only be performed for patients with [disease stage] [disease name]. | *[Surgical procedure] can only be performed for patients with [disease stage] [disease name]. | ||
=== Prevention === | ===Prevention=== | ||
*There are no primary preventive measures available for [disease name]. | *There are no primary preventive measures available for [disease name]. | ||
Revision as of 15:39, 21 May 2021
Template:Gut brain axis
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Sogand Goudarzi, MD [2]
Overview
Historical Perspective
- The gut–brain axis is the biochemical signaling between the central nervous system (CNS) and the gastrointestinal tract (GI tract).
- Gut brian axis was first discovered by [scientist name], a [nationality + occupation], in [year] during/following [event].
- In [year], [gene] mutations were first identified in the pathogenesis of [disease name].
- In [year], the first [discovery] was developed by [scientist] to treat/diagnose [disease name].
Classification
- [Disease name] may be classified according to [classification method] into [number] subtypes/groups:
- [group1]
- [group2]
- [group3]
- Other variants of [disease name] include [disease subtype 1], [disease subtype 2], and [disease subtype 3].
Pathophysiology
- The pathogenesis of [disease name] is characterized by [feature1], [feature2], and [feature3].
- The [gene name] gene/Mutation in [gene name] has been associated with the development of [disease name], involving the [molecular pathway] pathway.
- On gross pathology, [feature1], [feature2], and [feature3] are characteristic findings of [disease name].
- On microscopic histopathological analysis, [feature1], [feature2], and [feature3] are characteristic findings of [disease name].
Causes
Disease name] may be caused by [cause1], [cause2], or [cause3].
OR
Common causes of [disease] include [cause1], [cause2], and [cause3].
OR
The most common cause of [disease name] is [cause 1]. Less common causes of [disease name] include [cause 2], [cause 3], and [cause 4].
OR
The cause of [disease name] has not been identified. To review risk factors for the development of [disease name], click here.
Differentiating [disease name] from other Diseases
- [Disease name] must be differentiated from other diseases that cause [clinical feature 1], [clinical feature 2], and [clinical feature 3], such as:
- [Differential dx1]
- [Differential dx2]
- [Differential dx3]
Epidemiology and Demographics
- The prevalence of [disease name] is approximately [number or range] per 100,000 individuals worldwide.
- In [year], the incidence of [disease name] was estimated to be [number or range] cases per 100,000 individuals in [location].
Age
- Patients of all age groups may develop [disease name].
- [Disease name] is more commonly observed among patients aged [age range] years old.
- [Disease name] is more commonly observed among [elderly patients/young patients/children].
Gender
- [Disease name] affects men and women equally.
- [Gender 1] are more commonly affected with [disease name] than [gender 2].
- The [gender 1] to [Gender 2] ratio is approximately [number > 1] to 1.
Race
- There is no racial predilection for [disease name].
- [Disease name] usually affects individuals of the [race 1] race.
- [Race 2] individuals are less likely to develop [disease name].
Risk Factors
- Common risk factors in the development of [disease name] are [risk factor 1], [risk factor 2], [risk factor 3], and [risk factor 4].
Natural History, Complications and Prognosis
- The majority of patients with [disease name] remain asymptomatic for [duration/years].
- Early clinical features include [manifestation 1], [manifestation 2], and [manifestation 3].
- If left untreated, [#%] of patients with [disease name] may progress to develop [manifestation 1], [manifestation 2], and [manifestation 3].
- Common complications of [disease name] include [complication 1], [complication 2], and [complication 3].
- Prognosis is generally [excellent/good/poor], and the [1/5/10year mortality/survival rate] of patients with [disease name] is approximately [#%].
Diagnosis
Diagnostic Criteria
- The diagnosis of [disease name] is made when at least [number] of the following [number] diagnostic criteria are met:
- [criterion 1]
- [criterion 2]
- [criterion 3]
- [criterion 4]
History and Symptoms
- [Disease name] is usually asymptomatic.
- Symptoms of [disease name] may include the following:
- [symptom 1]
- [symptom 2]
- [symptom 3]
- [symptom 4]
- [symptom 5]
- [symptom 6]
Physical Examination
- Patients with [disease name] usually appear [general appearance].
- Physical examination may be remarkable for:
- [finding 1]
- [finding 2]
- [finding 3]
- [finding 4]
- [finding 5]
- [finding 6]
Laboratory Findings
- There are no specific laboratory findings associated with [disease name].
- A [positive/negative] [test name] is diagnostic of [disease name].
- An [elevated/reduced] concentration of [serum/blood/urinary/CSF/other] [lab test] is diagnostic of [disease name].
- Other laboratory findings consistent with the diagnosis of [disease name] include [abnormal test 1], [abnormal test 2], and [abnormal test 3].
Electrocardiogram
There are no ECG findings associated with [disease name].
OR
An ECG may be helpful in the diagnosis of [disease name]. Findings on an ECG suggestive of/diagnostic of [disease name] include [finding 1], [finding 2], and [finding 3].
X-ray
There are no x-ray findings associated with [disease name].
OR
An x-ray may be helpful in the diagnosis of [disease name]. Findings on an x-ray suggestive of/diagnostic of [disease name] include [finding 1], [finding 2], and [finding 3].
OR
There are no x-ray findings associated with [disease name]. However, an x-ray may be helpful in the diagnosis of complications of [disease name], which include [complication 1], [complication 2], and [complication 3].
Echocardiography or Ultrasound
There are no echocardiography/ultrasound findings associated with [disease name].
OR
Echocardiography/ultrasound may be helpful in the diagnosis of [disease name]. Findings on an echocardiography/ultrasound suggestive of/diagnostic of [disease name] include [finding 1], [finding 2], and [finding 3].
OR
There are no echocardiography/ultrasound findings associated with [disease name]. However, an echocardiography/ultrasound may be helpful in the diagnosis of complications of [disease name], which include [complication 1], [complication 2], and [complication 3].
CT scan
There are no CT scan findings associated with [disease name].
OR
[Location] CT scan may be helpful in the diagnosis of [disease name]. Findings on CT scan suggestive of/diagnostic of [disease name] include [finding 1], [finding 2], and [finding 3].
OR
There are no CT scan findings associated with [disease name]. However, a CT scan may be helpful in the diagnosis of complications of [disease name], which include [complication 1], [complication 2], and [complication 3].
MRI
There are no MRI findings associated with [disease name].
OR
[Location] MRI may be helpful in the diagnosis of [disease name]. Findings on MRI suggestive of/diagnostic of [disease name] include [finding 1], [finding 2], and [finding 3].
OR
There are no MRI findings associated with [disease name]. However, a MRI may be helpful in the diagnosis of complications of [disease name], which include [complication 1], [complication 2], and [complication 3].
Other Imaging Findings
There are no other imaging findings associated with [disease name].
OR
[Imaging modality] may be helpful in the diagnosis of [disease name]. Findings on an [imaging modality] suggestive of/diagnostic of [disease name] include [finding 1], [finding 2], and [finding 3].
Other Diagnostic Studies
There are no other diagnostic studies associated with [disease name].
OR
[Diagnostic study] may be helpful in the diagnosis of [disease name]. Findings suggestive of/diagnostic of [disease name] include [finding 1], [finding 2], and [finding 3].
OR
Other diagnostic studies for [disease name] include [diagnostic study 1], which demonstrates [finding 1], [finding 2], and [finding 3], and [diagnostic study 2], which demonstrates [finding 1], [finding 2], and [finding 3].
Treatment
Medical Therapy
- There is no treatment for [disease name]; the mainstay of therapy is supportive care.
- The mainstay of therapy for [disease name] is [medical therapy 1] and [medical therapy 2].
- [Medical therapy 1] acts by [mechanism of action 1].
- Response to [medical therapy 1] can be monitored with [test/physical finding/imaging] every [frequency/duration].
Surgery
- Surgery is the mainstay of therapy for [disease name].
- [Surgical procedure] in conjunction with [chemotherapy/radiation] is the most common approach to the treatment of [disease name].
- [Surgical procedure] can only be performed for patients with [disease stage] [disease name].
Prevention
- There are no primary preventive measures available for [disease name].
- Effective measures for the primary prevention of [disease name] include [measure1], [measure2], and [measure3].
- Once diagnosed and successfully treated, patients with [disease name] are followed-up every [duration]. Follow-up testing includes [test 1], [test 2], and [test 3].